Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free NRXP Stock Alerts

NRx Pharmaceuticals (NRXP) Institutional Ownership

NRx Pharmaceuticals logo
$3.08 +0.03 (+0.82%)
As of 03:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)

Current
Institutional Ownership
Percentage
4.27%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$10.83M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$294.87K
Get NRXP Insider Trade Alerts

Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NRXP Institutional Buying and Selling by Quarter

NRx Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/5/2026 Ethos Financial Group LLC15,900$34K0.0%+33.6%0.048%
4/28/2026 AdvisorShares Investments LLC420,467$896K0.2%+28.2%1.271%
2/17/2026Anson Funds Management LP3,043,957$8.25M0.8%+50.3%10.284%
2/13/2026State Street Corp86,984$236K0.0%+14.0%0.294%
2/12/2026 Commonwealth Equity Services LLC366,631$994K0.0%N/A1.238%
2/10/2026 AdvisorShares Investments LLC328,004$889K0.1%-4.1%1.108%
2/9/2026Geode Capital Management LLC218,866$593K0.0%+17.8%0.739%
2/9/2026 Bleakley Financial Group LLC117,204$318K0.0%N/A0.396%
2/6/2026Global Retirement Partners LLC39,300$107K0.0%N/A0.133%
1/14/2026 Sjbenen Advisory LLC15,000$41K0.0%N/A0.051%
1/14/2026One Wealth Management Investment & Advisory Services LLC37,873$103K0.1%+35.3%0.128%
11/17/2025Anson Funds Management LP2,025,104$6.68M0.6%+26.2%10.223%
11/14/2025Two Sigma Investments LP52,332$173K0.0%+66.4%0.264%
11/7/2025Vanguard Group Inc.534,956$1.77M0.0%+18.3%2.700%
11/5/2025 AdvisorShares Investments LLC342,136$1.13M0.2%+29.7%1.727%
10/29/2025One Wealth Management Investment & Advisory Services LLC27,991$92K0.1%+86.1%0.141%
10/23/2025 Ethos Financial Group LLC11,900$39K0.0%N/A0.060%
8/13/2025Marshall Wace LLP33,384$109K0.0%-62.5%0.193%
8/8/2025Geode Capital Management LLC172,255$562K0.0%+27.9%0.996%
8/4/2025 AdvisorShares Investments LLC263,797$860K0.2%-8.0%1.526%
5/28/2025Anson Funds Management LP1,179,061$2.42M0.4%+535.1%6.820%
5/14/2025Anson Funds Management LP1,179,061$2.42M0.3%+535.1%6.845%
2/17/2025Squarepoint Ops LLC25,299$56K0.0%N/A0.161%
2/17/2025Millennium Management LLC27,624$61K0.0%N/A0.176%
2/17/2025Anson Funds Management LP185,660$408K0.0%+30.3%1.183%
2/14/2025AdvisorShares Investments LLC310,314$683K0.1%+138.5%1.977%
2/14/2025Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096%
11/15/2024Anson Funds Management LP142,525$241K0.0%N/A1.326%
11/13/2024Townsquare Capital LLC15,041$25K0.0%N/A0.140%
8/8/2024AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010%
8/6/2024One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141%
2/14/2024AdvisorShares Investments LLC642,632$296K0.1%N/A0.755%
1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165%
11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398%
5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065%
2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086%
1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044%
1/27/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%
1/18/2023Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040%
11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094%
5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023%
4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027%
2/9/2022Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063%
2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020%


NRXP Institutional Ownership - Frequently Asked Questions

During the previous two years, 17 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were Anson Funds Management LP ($8.25M), Vanguard Group Inc. ($1.77M), Commonwealth Equity Services LLC ($994K), AdvisorShares Investments LLC ($896K), Geode Capital Management LLC ($593K), Bleakley Financial Group LLC ($318K), and State Street Corp ($236K).Learn more on NRx Pharmaceuticals' institutional investors.

4.27% of NRx Pharmaceuticals' stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings.

Of the 16 institutional investors that purchased NRx Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($3.61M), Commonwealth Equity Services LLC ($366.63K), AdvisorShares Investments LLC ($351.03K), Bleakley Financial Group LLC ($117.20K), Vanguard Group Inc. ($82.78K), Geode Capital Management LLC ($70.60K), and Global Retirement Partners LLC ($39.30K).

Institutional investors have bought a total of 4,358,416 shares in the last 24 months. This purchase volume represents approximately $10.83M in transactions.

The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: Marshall Wace LLP ($55.70K), and AdvisorShares Investments LLC ($37.13K).

Institutional investors have sold a total of 92,834 shares in the last 24 months. This volume of shares sold represents approximately $294.87K in transactions.


Related Companies

This page (NASDAQ:NRXP) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
May 13: The Fed Shock is about to hit the markets
Wall Street quantitative analyst Louis Navellier says a rare Federal Reserve regime change is opening a market...
Stansberry Research | Sponsoredtc pixel